Ibis Reproductive Health

For Support Of The Oral Contraceptives Over-the-Counter Project

Overview
A recent national survey in the US found that 41 per cent of women not currently using contraception said they would start using the pill, patch, or vaginal ring if it were available over the counter. A half-century of evidence also shows that providing the pill over the counter would be safe and effective. Recommended funds for this grant would support the Oral Contraceptives Over-the-Counter Working Group, a coalition sponsored by Hewlett grantee Ibis Reproductive Health working to provide easier access to affordable contraceptives through the registration in the U.S. of a low-cost oral contraceptive for sale without a prescription. With prior support from the Foundation the Working Group has surveyed stakeholders including pharmaceutical companies and women's health advocates to map out support and points of concern, and developed a detailed plan towards the ultimate goal of over the counter status for the pill.
About the Grantee
Address
2067 Massachusetts Avenue, Suite 320, Cambridge, MA, 02140, United States
Grants to this Grantee
for general operating support  
This supplemental grant is for Ibis’ expanded programmatic work to meet the recent challenges in the reproductive health, rights, and justice landscape in the United States. In order to help Ibis meet the moment, U.S. Reproductive Equity is providing this additional funding. Ibis Reproductive Health improves women’s reproductive autonomy, choices, and health by conducting research and pursuing principled partnerships in the United States, Latin America, and sub-Saharan Africa to inform advocacy for access to safe, affordable, high-quality reproductive health care. Ibis works to increase access to high-quality abortion services, transform access to abortion and contraception through technology and service innovations, and expand comprehensive sexual and reproductive health information and services. This grant is aligned with both the Global and U.S. Reproductive Equity strategies.
for general operating support  
Ibis Reproductive Health improves women’s reproductive autonomy, choices, and health by conducting research and pursuing principled partnerships in the United States, Latin America, and sub-Saharan Africa to inform advocacy for access to safe, affordable, high-quality reproductive health care. Ibis works to increase access to high-quality abortion services, transform access to abortion and contraception through technology and service innovations, and expand comprehensive sexual and reproductive health information and services. This grant is aligned with both the Global and U.S. Reproductive Equity strategies.
for general operating support  
Ibis Reproductive Health improves women’s reproductive autonomy, choices, and health by conducting research in the United States, Latin America, and sub-Saharan Africa to inform advocacy for access to safe, affordable, high-quality reproductive health care. During this grant period, Ibis’ efforts will include a focus on testing new approaches to measure the quality of abortion services and abortion stigma, building new partnerships with service delivery and advocacy groups that can best identify their communities’ research needs, and managing the effort to make an oral contraceptive available over-the-counter in the United States.

Search Our Grantmaking


By Keyword